JBM (Healthcare) Limited (HKG:2161)
Hong Kong · Delayed Price · Currency is HKD 2.780
+0.060 (2.21%)
At close: Feb 13, 2026
JBM (Healthcare) Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 216.39 | 197.26 | 130.46 | 57.09 | 24.62 | 22.6 |
Depreciation & Amortization | 53.5 | 52.28 | 46.52 | 43.63 | 47.78 | 43.6 |
Loss (Gain) From Sale of Assets | 0.12 | 0.12 | 0.01 | 0.13 | 0.01 | 0.2 |
Asset Writedown & Restructuring Costs | - | - | - | - | 2.5 | - |
Loss (Gain) From Sale of Investments | -1.02 | -1.02 | - | -8.9 | - | - |
Loss (Gain) on Equity Investments | -0.07 | -0.07 | -3.65 | 1.93 | 1.79 | 1.19 |
Stock-Based Compensation | 5.62 | 5.62 | 9.03 | 0.25 | - | - |
Other Operating Activities | -55.26 | 3.38 | 21.61 | 16.27 | -4.43 | 14.73 |
Change in Accounts Receivable | -20.4 | -20.4 | -11.73 | 18.65 | -3.21 | -22.4 |
Change in Inventory | 9.34 | 9.34 | -37.02 | -6.69 | 0.14 | 15.76 |
Change in Accounts Payable | -19.58 | -19.58 | 35.99 | 23.25 | -9.21 | -16.92 |
Operating Cash Flow | 188.65 | 226.94 | 191.22 | 145.62 | 60 | 58.76 |
Operating Cash Flow Growth | -27.84% | 18.68% | 31.31% | 142.71% | 2.11% | 53.47% |
Capital Expenditures | -29.99 | -21.01 | -10.21 | -8.13 | -7.06 | -22.96 |
Sale of Property, Plant & Equipment | - | - | 0.16 | 0.04 | - | - |
Cash Acquisitions | -199.42 | -102.6 | - | 1.86 | - | - |
Investment in Securities | 0.29 | 1.56 | 17.6 | -0.82 | -0.51 | -1.67 |
Other Investing Activities | 1.56 | 1.57 | 0.76 | 0.27 | 0.02 | 0.18 |
Investing Cash Flow | -227.56 | -120.48 | 8.31 | -6.78 | -7.55 | -24.45 |
Long-Term Debt Issued | - | 279.8 | 64 | 240 | - | 250 |
Total Debt Issued | 712.97 | 279.8 | 64 | 240 | - | 250 |
Short-Term Debt Repaid | - | - | - | - | - | -1.13 |
Long-Term Debt Repaid | - | -260.65 | -117.19 | -277.25 | -69.49 | -412.14 |
Total Debt Repaid | -450.95 | -260.65 | -117.19 | -277.25 | -69.49 | -413.26 |
Net Debt Issued (Repaid) | 262.03 | 19.15 | -53.19 | -37.25 | -69.49 | -163.26 |
Issuance of Common Stock | - | - | - | - | - | 53.62 |
Repurchase of Common Stock | -0.79 | -22.4 | -95.36 | -5.35 | - | - |
Common Dividends Paid | -139.08 | -78.7 | -52.71 | -4.47 | - | - |
Other Financing Activities | -44.71 | 40.41 | -9.46 | -8.97 | -7.37 | 95.72 |
Financing Cash Flow | 77.44 | -41.54 | -210.72 | -56.04 | -76.85 | -13.92 |
Foreign Exchange Rate Adjustments | -0.02 | 0.13 | -0.26 | -0.37 | -0.13 | 1.2 |
Net Cash Flow | 38.51 | 65.04 | -11.46 | 82.42 | -24.53 | 21.59 |
Free Cash Flow | 158.66 | 205.92 | 181 | 137.48 | 52.94 | 35.8 |
Free Cash Flow Growth | -37.63% | 13.77% | 31.65% | 159.71% | 47.88% | 6.03% |
Free Cash Flow Margin | 19.52% | 26.32% | 27.91% | 26.42% | 13.03% | 9.01% |
Free Cash Flow Per Share | 0.18 | 0.23 | 0.20 | 0.15 | 0.06 | 0.04 |
Cash Interest Paid | 5.57 | 4.46 | 8.5 | 8.21 | 6.41 | 2.86 |
Cash Income Tax Paid | 47.81 | 43.92 | 20.56 | 11.47 | 16.95 | 11.59 |
Levered Free Cash Flow | 90.95 | 141.65 | 155.92 | 131.68 | 48.75 | 40.97 |
Unlevered Free Cash Flow | 94.43 | 144.44 | 161.23 | 136.81 | 52.75 | 45.6 |
Change in Working Capital | -30.64 | -30.64 | -12.76 | 35.21 | -12.28 | -23.55 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.